Investigating the effect of curcumin capsules on cisplatin-induced kidney damage
Phase 3
Recruiting
- Conditions
- cancer.
- Registration Number
- IRCT20221211056777N3
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Cancer patients over 5 years of age who are being treated with cisplatin
be the same in terms of medications and supplements taken
Absence of kidney tumor
No kidney failure
Exclusion Criteria
Diagnosing the presence of kidney stones in patients
Patient non-cooperation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method